RA Capital Management »

Bright Minds Biosciences shares owned by RA Capital Management

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 265k 72.97
2025-03-31 $7.4M 206k 36.07
2024-12-31 $17M 461k 36.02

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences